The chemical class designated as transgelin-3 Activators comprises a diverse range of compounds that indirectly influence the activity of transgelin-3, a protein primarily involved in cytoskeletal organization and smooth muscle cell function. This class is characterized not by direct interaction with transgelin-3, but rather by the modulation of various cellular pathways and processes that in turn can impact the function or regulation of this protein. The compounds within this class, such as Forskolin, Phorbol 12-myristate 13-acetate (PMA), and Y-27632, employ distinct mechanisms to exert their influence. Forskolin, for instance, by elevating cAMP levels, can affect signaling pathways governing cytoskeletal dynamics, thereby potentially modulating transgelin-3's interaction with cytoskeletal components. PMA activates protein kinase C (PKC), which plays a significant role in the regulation of cytoskeletal organization, a process crucial to transgelin-3's function. Similarly, Y-27632, as a ROCK inhibitor, has the potential to impact actin cytoskeleton dynamics, which is central to the roles played by transgelin-3 in smooth muscle cells and other tissue types.
Further exploring the diversity of this class, compounds such as Blebbistatin, ML-7, and Calyculin A demonstrate how targeting different aspects of smooth muscle function and cytoskeletal regulation can indirectly affect transgelin-3. Blebbistatin inhibits myosin II, a pivotal component in muscle contraction, thereby potentially influencing transgelin-3's role in these cells. ML-7's inhibition of myosin light chain kinase and Calyculin A's effect on protein phosphatases highlight the complex regulation of cytoskeletal dynamics, which can have ramifications for transgelin-3 activity. Additionally, agents like Jasplakinolide, Latrunculin A, and Cytochalasin D, which modulate actin filament stability and dynamics, represent another aspect of this chemical class. These compounds, by altering the stability and polymerization of actin, can indirectly modulate transgelin-3's function in cytoskeletal organization. Moreover, Ionomycin, through its role in increasing intracellular calcium, and inhibitors like PD98059 and SB203580, which affect the MAPK/ERK and p38 MAPK pathways, respectively, illustrate the breadth of signaling pathways that can intersect with transgelin-3's role in the cell. Overall, the transgelin-3 Activators class encompasses a multifaceted approach to influencing a key protein involved in cytoskeletal dynamics and smooth muscle function, reflecting the intricate network of cellular signaling and structural regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Increases cAMP levels, potentially affecting signaling pathways that regulate cytoskeletal proteins like transgelin- | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC, possibly influencing transgelin-3 by modulating the cytoskeletal organization. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Stabilizes actin filaments, which may indirectly affect transgelin-3's interaction with the cytoskeleton. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Binds to actin monomers, potentially affecting transgelin-3's role in cytoskeletal organization. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Disrupts actin polymerization, potentially impacting transgelin-3's role in cytoskeletal dynamics. | ||||||